SEC Form 4 · accession 0001127602-17-014069
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert O. Kraft
Officer — EVP and President - Omnicare
Period of report
Apr 3, 2017
Accepted (ET)
Apr 4, 2017 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (restricted)F1 | Apr 3, 2017 | A | 5,124 | $78.05 | A | 92,360 | D | |
| Common Stock | holding | — | — | — | 9,966 | D | ||
| Common Stock (pep) | holding | — | — | — | 5,661 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $78.05 | Apr 3, 2017 | A | 40,071 | A | Apr 3, 2018 | Apr 3, 2024 | Common Stock | 40,071 | 40,071 | D |
| Stock OptionF3 | $104.82 | holding | — | — | — | Apr 1, 2017 | Apr 1, 2023 | Common Stock | 23,301 | 23,301 | D |
| Stock OptionF4 | $102.40 | holding | — | — | — | Aug 31, 2018 | Aug 31, 2025 | Common Stock | 55,020 | 55,020 | D |
Explanation of responses
- F1Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.
- F2Option becomes exercisable in four equal annual installments, commencing 4/3/2018.
- F3Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
- F4Option becomes exercisable in three equal annual installments, commencing 8/31/2018.